These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21717671)

  • 1. [From the physiology of pain to an antihyperalgesic nutritional approach].
    de la Brière A
    Soins; 2011 May; (755):18-20. PubMed ID: 21717671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid induced hyperalgesia: clinical implications for the pain practitioner.
    Silverman SM
    Pain Physician; 2009; 12(3):679-84. PubMed ID: 19461836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nociception increases during opioid infusion in opioid receptor triple knock-out mice.
    Juni A; Klein G; Pintar JE; Kest B
    Neuroscience; 2007 Jun; 147(2):439-44. PubMed ID: 17544222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low doses ketamine: antihyperalgesic drug, non-analgesic].
    Richebé P; Rivat C; Rivalan B; Maurette P; Simonnet G
    Ann Fr Anesth Reanim; 2005; 24(11-12):1349-59. PubMed ID: 16115745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pain risk factor. Preventing memory of pain].
    MMW Fortschr Med; 2002 May; Suppl 2():70-1. PubMed ID: 12070856
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complexity and physiology of the analgesic effects of opioids].
    Simonnet G
    Rev Med Suisse; 2005 Jun; 1(25):1682-5. PubMed ID: 16117034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic modulation in pain pathways.
    Zeilhofer HU
    Rev Physiol Biochem Pharmacol; 2005; 154():73-100. PubMed ID: 16059718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The clinical relevance of opioid-induced hyperalgesia remains unresolved].
    Sørensen J; Sjøgren P
    Ugeskr Laeger; 2011 Mar; 173(13):965-8. PubMed ID: 21453637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive review of opioid-induced hyperalgesia.
    Lee M; Silverman SM; Hansen H; Patel VB; Manchikanti L
    Pain Physician; 2011; 14(2):145-61. PubMed ID: 21412369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Opioids and the occurrence of pain].
    Herz A
    Internist (Berl); 1986 Jul; 27(7):412-7. PubMed ID: 2875044
    [No Abstract]   [Full Text] [Related]  

  • 11. An antisense oligonucleotide to the N-methyl-D-aspartate (NMDA) subunit NMDAR1 attenuates NMDA-induced nociception, hyperalgesia, and morphine tolerance.
    Shimoyama N; Shimoyama M; Davis AM; Monaghan DT; Inturrisi CE
    J Pharmacol Exp Ther; 2005 Feb; 312(2):834-40. PubMed ID: 15388787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primed for pain.
    Servick K
    Science; 2016 Nov; 354(6312):569-571. PubMed ID: 27811266
    [No Abstract]   [Full Text] [Related]  

  • 13. [A breakthrough in the research on pain. Survey of the synaptic network may result in new analgesics].
    Olgart L
    Lakartidningen; 1997 Nov; 94(48):4461-6. PubMed ID: 9424546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid tolerance and hyperalgesia.
    Chang G; Chen L; Mao J
    Med Clin North Am; 2007 Mar; 91(2):199-211. PubMed ID: 17321281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Opioid tolerance: a phenomenon of latent hyperalgesia].
    Gao JL; Zhou WH; Yang GD
    Sheng Li Ke Xue Jin Zhan; 2001 Jul; 32(3):265-8. PubMed ID: 12545806
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuropathic pain: the paradox of dynorphin.
    Lai J; Ossipov MH; Vanderah TW; Malan TP; Porreca F
    Mol Interv; 2001 Aug; 1(3):160-7. PubMed ID: 14993349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia.
    Klein T; Magerl W; Hanschmann A; Althaus M; Treede RD
    Eur J Pain; 2008 Jan; 12(1):17-29. PubMed ID: 17449306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sevoflurane on carrageenan- and fentanyl-induced pain hypersensitivity in Sprague-Dawley rats.
    Richebé P; Rivalan B; Rivat C; Laulin JP; Janvier G; Maurette P; Simonnet G
    Can J Anaesth; 2009 Feb; 56(2):126-35. PubMed ID: 19247760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.